{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:56:11Z","timestamp":1777125371639,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["2024ZSQN21"],"award-info":[{"award-number":["2024ZSQN21"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jss.2025.07.038","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T10:04:09Z","timestamp":1755165849000},"page":"369-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacist-Led Genotype-Guided Warfarin Therapy in Valve Replacement: An Observation Cohort Study"],"prefix":"10.1016","volume":"314","author":[{"given":"Tianxiao","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2025.07.038_bib1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamacardio.2022.1591","article-title":"Subclinical leaflet thrombosis and anticoagulation after transcatheter aortic valve replacement: a review","volume":"7","author":"Cahill","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jss.2025.07.038_bib2","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.jcin.2023.10.024","article-title":"Frequency, predictors, and clinical impact of valvular and perivalvular thrombus after transcatheter aortic valve replacement","volume":"16","author":"Choi","year":"2023","journal-title":"JACC Cardiovasc Inter"},{"key":"10.1016\/j.jss.2025.07.038_bib3","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused Update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease A report of the American College of Cardiology\/American heart association task force on clinical Practice guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2025.07.038_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejcts.2006.12.017","article-title":"Antithrombotic therapy following bioprosthetic aortic valve replacement","volume":"31","author":"Nowell","year":"2007","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"10.1016\/j.jss.2025.07.038_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.thromres.2018.09.064","article-title":"Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: implications for patients undergoing surgery","volume":"171","author":"Abohelaika","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jss.2025.07.038_bib6","first-page":"554","article-title":"The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: a meta-analysis of randomized trials","volume":"8","author":"Zelniker","year":"2019","journal-title":"Eur Heart Journal-Acute Cardiovasc Care"},{"key":"10.1016\/j.jss.2025.07.038_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40256-016-0171-6","article-title":"A summary of the literature evaluating adherence and persistence with oral anticoagulants in atrial fibrillation","volume":"16","author":"Obamiro","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jss.2025.07.038_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MAJ.0b013e3182382553","article-title":"Warfarin resistance associated with parenteral Nutrition","volume":"343","author":"Cheung","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jss.2025.07.038_bib9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.clpt.6100316","article-title":"CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study","volume":"83","author":"Caraco","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jss.2025.07.038_bib10","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/phar.1982","article-title":"Warfarin pharmacogenomics in diverse populations","volume":"37","author":"Kaye","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jss.2025.07.038_bib11","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/bcp.14608","article-title":"Warfarin dosing algorithms: a systematic review","volume":"87","author":"Asiimwe","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jss.2025.07.038_bib12","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa044503","article-title":"Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose","volume":"352","author":"Rieder","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jss.2025.07.038_bib13","first-page":"13","article-title":"VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation","volume":"80","author":"Schalekamp","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jss.2025.07.038_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/GIM.0b013e318163c35f","article-title":"Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin","volume":"10","author":"Flockhart","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jss.2025.07.038_bib15","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/j.1538-7836.2010.04051.x","article-title":"Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis","volume":"8","author":"Saokaew","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jss.2025.07.038_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11096-011-9597-8","article-title":"Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand","volume":"34","author":"Saokaew","year":"2012","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jss.2025.07.038_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","author":"Klein","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jss.2025.07.038_bib18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11239-013-0867-2","article-title":"Patients with stable, therapeutic INR values should remain on warfarin","volume":"35","author":"Garcia","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jss.2025.07.038_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2017.12.008","article-title":"Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation","volume":"197","author":"Fanning","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jss.2025.07.038_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/heartjnl-2017-312514","article-title":"Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement","volume":"104","author":"Del Trigo","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jss.2025.07.038_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ejcts\/ezx324","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"52","author":"Falk","year":"2017","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"10.1016\/j.jss.2025.07.038_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/pgs-2021-0109","article-title":"Changing from mandatory to optional genotyping results in higher acceptance of pharmacist-guided warfarin dosing","volume":"23","author":"Zolekar","year":"2021","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jss.2025.07.038_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1378\/chest.14-2947","article-title":"Meta-analysis of randomized controlled trials of genotype-guided vs standard dosing of warfarin","volume":"148","author":"Dahal","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jss.2025.07.038_bib24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jamainternmed.2014.2368","article-title":"Genotype-guided vs clinical dosing of warfarin and its analogues meta-analysis of randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"Jama Intern Med"},{"key":"10.1016\/j.jss.2025.07.038_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jhg.2011.4","article-title":"Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients","volume":"56","author":"Choi","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jss.2025.07.038_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1182\/blood-2015-02-627042","article-title":"Race influences warfarin dose changes associated with genetic factors","volume":"126","author":"Limdi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jss.2025.07.038_bib30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/tpj.2016.57","article-title":"Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms","volume":"17","author":"Kubo","year":"2017","journal-title":"Pharmacogenomics J"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425004822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480425004822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:32:02Z","timestamp":1777123922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480425004822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"alternative-id":["S0022480425004822"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2025.07.038","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacist-Led Genotype-Guided Warfarin Therapy in Valve Replacement: An Observation Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2025.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}